Abstract
Aegle marmelos (L.), a pharmacologically useful shrub is a native to central Asia. Due to the richness of therapeutically active ingredients, it holds significance in conditions such as cardiovascular diseases, osteoporosis, neurodegenerative disorders, cancer, and inflammatory disorders. These properties are attributed to the presence of various phytoconstituents present in the plant such as coumarins, alkaloids, tannins, phenols, flavonoids. This study focuses on studying the leaf extracts of Bael on different cell lines: MCF7, MDA-MB-231, HepG2, and A549. The cytotoxicity of the leaf extracts was studied against these cancer cell lines using MTT (3- [4,5- dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay. The toxicity of the extracts against cancer cell lines was evaluated by determining the IC50 (Half maximal inhibitory concentration) value and the results were as follows, the IC50 against HepG2 cell line was 129.1µg/ml, for MDA-MB-231 it was 130.34 µg/ml, for A549 and MCF7 it was 239.5 µg/ml and 234.49 µg/ml respectively. This indicates the effectiveness of Aegle marmelos leaf extracts against liver, lung, and breast cancer cell lines. To verify the potency of this extract as an anti-cancer agent, the standard doxorubicin was used to compare the results. The evaluation of the extract shows the medicinal importance of this plant in cure of multiple diseases. It can be used as a combinatorial therapy with other drugs to verify the synergy in the cure of cancer.